- About this Module
- Co-Editors Welcome
- Introduction
- The History of CAD
- Definitions & Classification
- Pathophysiology
- Evolutionary Medicine
- Epidemiology
- Clinical Presentation
- Quality of Life & Disease Burden
- Diagnosis
- Treatment
- Longitudinal Care
- Patient and Clinician Resources
- Consult Practice
- Humanities, Meaning & Experience
- Landmark Studies in CAD
- Clinical Practice Guidance and Expert Reviews in CAD
- Beyond the Guidelines
- Clinical Cases
- Test Your Understanding
- Media Library

Diagnosis of CAD
Dr. Sigbjørn Berentsen
Consultant Hematologist and Senior Researcher
Former Associate Professor at the University of Bergen
Department of Research and Innovation
Haugesund Hospital, Norway

Precision Diagnostics in CAD
Dr. Yoshitaka Miyakawa
Professor of the Department of Hematology
Saitama Medical University
Saitama, Japan

CAD: Two Mechanisms,
Two Treatment Questions
Dr. Ilene C. Weitz
Professor of Medicine
Keck School of Medicine
University of Southern California (USC)
Los Angeles, California, USA

Sutimlimab for CAD – Pivotal Studies
Dr. Catherine Broome
Professor of Medicine, Division of Hematology & Oncology
Georgetown University Lombardi Cancer Center
Washington, DC, USA

B-Cell Directed Therapy for CAD
Dr. Marc Michel
Deputy Director, Department of Medicine
Henri Mondor University Hospitals
Assistance Publique–Hôpitaux de Paris (AP-HP)
University of Paris-Est Créteil

Complications of CAD Therapy
Dr. Bruno Fattizzo
Hematologist and Assistant Professor
Policlinico Hospital
University of Milan, Italy.